Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1899)
NICE advice (321)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (792)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (253)
Apply filters
Showing 771 to 780 of 2418
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
TA374
16 December 2015
16 December 2015
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
TA258
27 June 2012
27 June 2012
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer
TA227
29 June 2011
29 June 2011
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes
TA572
27 March 2019
27 March 2019
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes
TA583
5 June 2019
5 June 2019
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
TA323
26 November 2014
26 November 2014
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)
TA899
6 June 2023
6 June 2023
Esketamine nasal spray for treatment-resistant depression
TA854
14 December 2022
14 December 2022
Etanercept and efalizumab for the treatment of adults with psoriasis
TA103
26 July 2006
26 July 2006
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
TA199
25 August 2010
25 August 2010
Previous page
1
…
76
77
Current page
78
79
80
…
242
Page
78
of
242
Next page
Results per page
10
25
50
All
Back to top